The Medical Advisor

Can High-Dose Vitamin C Improve Cancer Outcomes? Vitamin C has long been associated with immune health, but in recent years it has re-emerged in oncology research — not as a supplement, but as a pharmacologic agent when administered at very high doses intravenously. New clinical data, including a randomized phase II pancreatic cancer trial (2024) , suggest that high-dose IV vitamin C may significantly improve survival when added to standard chemotherapy , reigniting scientific and clinical interest in this once-controversial approach. This article consolidates and updates evidence from: Recent pancreatic cancer trials Mechanistic cancer biology research Earlier vitamin C oncology literature Modern combination therapy studies What Is High-Dose Vitamin C — and Why IV Matters High-dose vitamin C refers to pharmacologic concentrations of ascorbic acid (typically 50–100 grams per infusion ) administered intravenously . This distinction is critical: Oral vitamin C cannot achieve therapeu...

Pancreatic cancer is one of the most challenging forms of an already difficult disease. It sometimes dubbed the “ king of cancer “ due to its malignancy, poses challenges in both early detection and late-stage treatment. Despite relatively low incidence levels, it ranks seventh among causes of global cancer deaths in industrialized countries and was the third most common cause of cancer mortality in the United States in 2020. Pancreatic Cancer Awareness Because patients seldom experience symptoms until the disease has reached an advanced stage, pancreatic cancer remains challenging to treat successfully. According to Johns Hopkins Medicine, 80 percent of cases aren’t diagnosed until later, difficult-to-treat stages. Thus, despite advancements in detection and management, the five-year survival rate is still only 5 to 10 percent . Common Types of Pancreatic Cancer There are two categories of pancreatic cancer—those that affect the exocrine cells in the pancreas and those that affect t...